Serum testosterone and estradiol in sudden infant death

Area of Science:

• Pediatric pathology
• Endocrinology
• Forensic science

Background:

• Sudden Infant Death Syndrome (SIDS) remains a leading cause of post-neonatal mortality.
• The underlying pathophysiology of SIDS is not fully understood.
• Hormonal factors, including androgens and estrogens, are being investigated for their potential role.

Purpose of the Study:

• To investigate serum testosterone and estradiol levels in infants diagnosed with SIDS.
• To compare hormone levels between SIDS cases and infants with known causes of death (controls).
• To test the hypothesis of elevated steroid hormone levels in SIDS.

Main Methods:

• Postmortem blood samples were collected from infant autopsies.
• Serum was analyzed for total testosterone and estradiol using fluoroimmunoassay.
• Medical examiner reports provided subject information for case-control matching.

Main Results:

• Testosterone levels were significantly higher in SIDS cases compared to controls for both males and females.
• No significant difference in estradiol levels was observed between SIDS cases and controls.
• Specifically, male SIDS cases had testosterone levels of 4.8 nmol vs. 2.2 nmol in controls (P < .005), and female SIDS cases had 2.4 nmol vs. 1.6 nmol (P < 0.03).

Conclusions:

• Elevated testosterone levels in infant victims of unexpected death may suggest a role for testosterone or related steroids in SIDS.
• These findings highlight the potential utility of testosterone as an indicator of SIDS risk.
• Further research is recommended to elucidate the precise mechanisms and implications of these hormonal differences.